David M Manyak insider trades: Caliper Life Sciences (CALP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 14, 2011 | CALP | ↓ Sell | 20,000 | $7.54 | $151K | Direct | Jun 15, 2011 (1d) |
| Jun 9, 2011 | CALP | ↓ Sell | 25,000 | $7.30 | $183K | Direct | Jun 9, 2011 (0d) |
| Jun 1, 2011 | CALP | ↓ Sell | 15,000 | $7.18 | $108K | Direct | Jun 2, 2011 (1d) |
| May 25, 2011 | CALP | ↓ Sell | 15,000 | $7.08 | $106K | Direct | May 26, 2011 (1d) |
| Oct 15, 2010 | CALP | ↓ Sell | 8,000 | $4.22 | $34K | Direct | Oct 15, 2010 (0d) |
| Oct 13, 2010 | CALP | ↓ Sell | 12,000 | $4.17 | $50K | Direct | Oct 13, 2010 (0d) |
| Mar 14, 2008 | CALP | ↓ Sell | 4,700 | $4.07 | $19K | Direct | Mar 17, 2008 (3d) |
| Dec 20, 2007 | CALP | ↓ Sell | 1,720 | $5.50 | $9K | Direct | Dec 20, 2007 (0d) |
| Dec 19, 2007 | CALP | ↓ Sell | 7,280 | $5.58 | $41K | Direct | Dec 19, 2007 (0d) |
| Dec 10, 2007 | CALP | ↓ Sell | 9,000 | $5.80 | $52K | Direct | Dec 10, 2007 (0d) |
| Dec 3, 2007 | CALP | ↓ Sell | 36,000 | $5.53 | $199K | Direct | Dec 3, 2007 (0d) |
| Nov 5, 2007 | CALP | ↓ Sell | 9,000 | $5.71 | $51K | Direct | Nov 7, 2007 (2d) |
| Oct 29, 2007 | CALP | ↓ Sell | 9,000 | $5.87 | $53K | Direct | Oct 30, 2007 (1d) |
| Oct 22, 2007 | CALP | ↓ Sell | 9,000 | $5.78 | $52K | Direct | Oct 23, 2007 (1d) |
| Oct 15, 2007 | CALP | ↓ Sell | 9,000 | $6.03 | $54K | Direct | Oct 17, 2007 (2d) |
| Sep 14, 2007 | CALP | ↓ Sell | 2,000 | $5.42 | $11K | Direct | Sep 17, 2007 (3d) |
| Sep 7, 2007 | CALP | ↓ Sell | 1,680 | $5.65 | $9K | Direct | Sep 13, 2007 (6d) |
| Nov 30, 2006 | CALP | ↓ Sell | 50,000 | $5.51 | $276K | Direct | Nov 30, 2006 (0d) |
| Mar 14, 2006 | CALP | ↓ Sell | 50,000 | $6.56 | $328K | Direct | Mar 16, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David M Manyak's insider trades
David M Manyak is Exec VP, Drug Discovery Svcs at Caliper Life Sciences (CALP). Since Mar 14, 2006, David has reported no open-market purchases and 19 sales worth $1.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (17 filings), option exercises (16 filings), grants and awards (9 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CALP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.